Applicant, as named in the Orange Book

Acacia

Next listed expiry: Byfavo on 13 Jan 2034. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Byfavo remimazolam besylate	remimazolam besylate	212295	13 Jan 2034	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.